| Schedule of Segment Net Loss and Reconciliations of Segment Operating Loss to Loss Before Income Tax Benefit |
The following table presents Recursion’s segment revenue, significant segment expenses and segment net loss:
| | | | | | | | | | | | | | | | | | | Three months ended June 30, | | Six months ended June 30, | | (In thousands) | 2026 | 2025 | | 2026 | 2025 | | Revenue | $ | 7,670 | | $ | 19,223 | | | $ | 14,143 | | $ | 33,968 | | | | | | | | | Significant segment expenses | | | | | | | Salaries | 67,170 | | 83,037 | | | 141,468 | | 166,591 | | | Consumables | 14,960 | | 29,121 | | | 22,106 | | 83,798 | | | Platform | 6,679 | | 13,792 | | | 14,293 | | 22,557 | | | Discovery | 4,044 | | 15,380 | | | 10,377 | | 21,667 | | | Clinical development | 10,673 | | 11,960 | | | 17,242 | | 22,524 | | | Depreciation and amortization | 18,167 | | 26,185 | | | 37,840 | | 45,516 | | | Other segment items | 20,945 | | 15,975 | | | 34,289 | | 38,910 | | | Loss from operations | 134,968 | | 176,227 | | | 263,472 | | 367,595 | | | Other non-operating income (loss), net | 3,962 | | 4,330 | | | 10,359 | | (6,947) | | | Income tax benefit | 1 | | — | | | 4,604 | | 158 | | | Total segment loss | $ | 131,005 | | $ | 171,897 | | | $ | 248,509 | | $ | 374,384 | | | | | | | | | Supplemental asset information | | | | | | | Total expenditures for additions to long-lived assets | $ | 43 | | $ | 2,266 | | | $ | 302 | | $ | 5,244 | |
|